Can CPAP Cause Carbon Dioxide Poisoning?

Standard CPAP therapy does not cause carbon dioxide poisoning under normal operating conditions, but CO₂ rebreathing is a recognized side effect that clinicians and patients frequently underestimate. Every time you exhale into a CPAP mask, some of that carbon dioxide–rich air lingers in the mask and tubing. On your next breath, you inhale a portion of it before fresh air flushes it out. In most cases the amount is trivial, but certain combinations of mask design, pressure settings, and patient physiology can push rebreathing into territory that causes real symptoms and, in rare equipment-failure scenarios, genuine danger.

How Carbon Dioxide Builds Up Inside a CPAP Circuit

A CPAP machine delivers a continuous stream of pressurized air through a hose and into a mask. That airflow serves two purposes: it splints your airway open to prevent apnea events, and it flushes exhaled CO₂ out through small vent holes built into the mask. The exhaust vents are doing quiet but critical work all night long. As long as the pressure is high enough and the vents are clear, the CO₂ you breathe out gets swept away before your next inhalation.

Problems start when the flush rate drops below what is needed to clear the dead space, which is the volume of air sitting inside the mask and any tubing between the mask and the vent. Three variables drive the risk: low positive airway pressure settings, high breathing rates, and large tidal volumes. A recent modeling and bench study found that all masks tested performed worse under conditions of low pressure, high tidal volume, and high respiratory rate, though the degree of vulnerability varied widely between mask designs.¹ When pressure is set low, airflow through the vents slows. When you breathe fast or deeply, you produce more CO₂ per minute than the circuit can clear. The result is that some fraction of each inhaled breath is recycled exhaled air.

A 2025 review described this as a self-reinforcing cycle: as CO₂ accumulates, the body’s natural response is to breathe harder and faster, which paradoxically worsens rebreathing by increasing ventilation demand beyond what the circuit can flush.² This feedback loop is one reason the issue can escalate overnight without the sleeper being aware of it.

Why Mask Choice Matters More Than Most People Realize

Not all CPAP masks create the same rebreathing risk. The internal volume of the mask, the size and placement of the exhaust vents, and whether you use a nasal pillow, nasal cradle, or full-face mask all affect how efficiently CO₂ is flushed. Bench testing has shown that masks with smaller internal volumes consistently retain less CO₂, and that a mask with two exhaust ports can keep inhaled CO₂ below the patient safety threshold of about one percent even without extra recirculation airflow.³

In the circuit-modeling study mentioned above, some popular mask models were far more susceptible to rebreathing than others under identical pressure and breathing conditions. Certain nasal pillow and nasal cradle designs showed negligible rebreathing risk at normal breathing rates of ten breaths per minute or less, while several full-face and hybrid masks showed substantially higher CO₂ retention under the same settings.¹ The practical takeaway is that if you experience unexplained morning headaches, grogginess, or a sense of air hunger on CPAP, the mask itself could be contributing, and switching to a lower-volume mask or one with better vent placement may help.

An older study using bilevel pressure found that nasal masks with proper exhalation valves showed zero rebreathing in healthy volunteers across all pressure levels tested. Full-face masks showed a small amount of rebreathing in one participant, likely because of the larger dead space volume.⁴ Full-face masks have inherently more internal volume than nasal masks, which means more exhaled air has to be cleared on each breath cycle. If you mouth-breathe and need a full-face mask, this is worth discussing with your sleep specialist.

The Ramp and Auto-Titration Problem

Many CPAP machines start the night at a low pressure and gradually ramp up to your prescribed level over ten, twenty, or thirty minutes. The idea is comfort: falling asleep against high pressure can feel like breathing into a wind tunnel. But during that ramp period, the pressure may be too low to adequately flush CO₂ from the mask. Researchers have flagged ramp settings and auto-titrating machines as contributors to rebreathing, noting that these features can keep pressure low precisely when patients are falling asleep and their breathing may already be unstable.⁵

Auto-titrating machines, which adjust pressure throughout the night based on detected airway resistance, can also drop pressure during periods of stable breathing. That is exactly what they are designed to do. But stable breathing does not mean CO₂ clearance is adequate, especially if the mask has marginal vent performance. The risk factors for rebreathing are often overlooked or poorly understood in everyday clinical practice, partly because standard sleep studies do not routinely measure CO₂ levels inside the mask.

What Equipment Failure Looks Like

The scenarios where CPAP genuinely becomes dangerous involve equipment malfunction or power loss. Common CPAP systems do not incorporate alarms, so if the device stops generating airflow while you are still wearing the mask, you end up breathing through a sealed or nearly sealed space with no fresh air supply.⁶ The exhaust vents in a standard mask are designed to work with pressurized airflow pushing through them; without that pressure, they allow only minimal passive air exchange. In theory, you would simply wake up. In practice, the arousal response can be blunted in people who are heavily sedated, on certain medications, or deeply sleep-deprived.

Helmet-style CPAP devices, which are used in some hospital settings rather than face masks, have been studied for this exact failure scenario. Researchers tested different helmet designs during simulated gas-supply failures and found that the speed of CO₂ buildup depended heavily on the helmet’s safety-valve design, with some helmets allowing dangerously rapid CO₂ accumulation when fresh gas flow stopped.⁷ This is mainly a concern for hospital CPAP setups, not home machines, but it illustrates why safety valves and alarm systems matter in any positive-pressure breathing device.

Symptoms That Suggest CO₂ Rebreathing

Carbon dioxide rebreathing during CPAP does not typically announce itself with dramatic symptoms. Instead, it tends to produce a cluster of complaints that overlap with other common CPAP issues: morning headaches, feeling unrested despite a full night of use, a sensation of struggling to breathe or not getting enough air, and in some cases vivid or disturbing dreams. Because these symptoms also show up with poor mask fit, mouth leaks, or undertreated apnea, rebreathing is easy to miss as a cause.

One study specifically noted that adding supplemental oxygen to CPAP therapy in patients with obesity hypoventilation syndrome increased the frequency of morning confusion, suggesting that blunting the body’s oxygen-driven breathing stimulus allowed CO₂ to accumulate further.⁸ Morning confusion in a CPAP user, particularly one who is also on supplemental oxygen, should prompt a check of CO₂ levels rather than a simple assumption that the patient is not sleeping well.

The gold-standard way to detect CO₂ issues during sleep is transcutaneous CO₂ monitoring, where a small sensor on the skin tracks blood CO₂ levels continuously overnight. This has been used during PAP titration studies to identify patients whose CO₂ climbs during the night.⁹ It is not part of a routine home CPAP setup, but if you have persistent symptoms that do not improve with mask adjustments or pressure changes, asking your sleep clinic about overnight CO₂ monitoring is reasonable.

When the Patient’s Own Physiology Is the Bigger Factor

For most people with straightforward obstructive sleep apnea, CPAP works well enough at clearing CO₂ that rebreathing remains a minor nuisance at worst. The picture changes substantially for patients who already have trouble getting rid of CO₂ because of an underlying condition. Obesity hypoventilation syndrome, chronic obstructive pulmonary disease, and neuromuscular disorders all impair the body’s ability to ventilate effectively, meaning even modest CO₂ rebreathing from a CPAP mask adds to an existing problem.

In patients with obesity hypoventilation syndrome, CPAP sometimes fails to adequately lower blood CO₂ levels. A pilot trial comparing CPAP to bilevel positive airway pressure in these patients found that bilevel therapy improved blood CO₂ by roughly nine more millimeters of mercury than CPAP did.¹⁰ A meta-analysis of studies comparing CPAP to noninvasive ventilation in obesity hypoventilation syndrome also found that noninvasive ventilation produced a significantly greater reduction in blood CO₂.¹¹ Bilevel machines deliver higher pressure on inhalation and lower pressure on exhalation, actively assisting ventilation rather than just splinting the airway open, which makes them better at washing out CO₂.

A case series of patients with obesity hypoventilation syndrome showed persistent high CO₂ levels, with transcutaneous readings above 50 mmHg, during CPAP titration studies, even when the CPAP appeared to be controlling obstructive events.¹² In other words, the apnea was being treated but the CO₂ problem was not. For these patients, the issue is less about CO₂ rebreathing from the mask and more about CPAP being the wrong tool for the job. The lungs cannot ventilate well enough on their own, and a device that only holds the airway open is not enough help.

Neuromuscular conditions create a similar mismatch. When the muscles responsible for breathing are weakened, positive-pressure ventilation that actively assists each breath becomes critical. Noninvasive ventilation has been described as a crucial advance in managing these patients, often preventing or delaying the need for mechanical ventilation and improving survival.¹³ Simple CPAP is usually not sufficient for this population.

Infants and Small Children Face Disproportionate Risk

Dead space is a fixed physical volume inside the mask. For an adult with a tidal volume of roughly 500 milliliters per breath, an extra 30 or 40 milliliters of dead space is a rounding error. For a newborn whose entire dead space is about 5.5 milliliters, the same extra volume is enormous. Modeling of infant facemasks has shown that the dead-space-to-tidal-volume ratio rises disproportionately in small patients because their absolute lung volumes are so much smaller, even though the relative dead space per kilogram of body weight is the same as in adults.¹⁴ Any mask or interface used on an infant therefore needs to minimize internal volume far more aggressively than adult equipment, because the margin for error is almost nonexistent.

This is one reason pediatric CPAP setups are designed differently from adult ones and why off-label use of adult masks on small children is strongly discouraged. The same physics apply to any small patient, including very small adults, though the effect is less extreme than in neonates.

Deliberate CO₂ Rebreathing as a Treatment

In a surprising twist, some sleep specialists deliberately increase CO₂ rebreathing as a therapy for a specific type of sleep apnea. High loop gain central sleep apnea is a condition where the brain’s breathing control system overreacts to small changes in blood CO₂, creating a cycle of over-breathing and under-breathing. One treatment approach, called enhanced expiratory rebreathing space, works by intentionally increasing the dead space in the CPAP circuit so the patient reinhales a controlled amount of CO₂. This stabilizes blood CO₂ levels and dampens the overshoot-undershoot cycle.

The technique involves blocking the mask’s normal exhaust vents, converting it to a non-vented setup, then adding measured lengths of corrugated tubing in 50-milliliter increments to increase dead space. A swivel exhalation valve at the far end of the added tubing provides continuous venting so CO₂ does not accumulate without limit. For full-face mask setups, a safety valve is also added to prevent suffocation if the machine loses power.¹⁵ The procedure is done under clinical supervision, not as a DIY modification, and it underscores an important point: CO₂ rebreathing is not inherently toxic. The dose, the context, and the patient’s physiology determine whether it is harmful, harmless, or therapeutic.

Practical Steps to Minimize Rebreathing at Home

If you use CPAP and want to reduce your exposure to rebreathing, several practical adjustments can help:

Check your vent holes: Make sure the mask’s exhaust ports are not clogged with dust, skin oil, or mineral deposits from humidifier water. Blocked vents directly reduce CO₂ clearance.
Reassess your mask type: If you use a full-face mask and experience morning headaches or air hunger, ask your provider about trying a nasal mask or nasal pillows, which have smaller dead space volumes.
Reconsider the ramp: If your machine uses a ramp feature that starts at very low pressure, shortening the ramp duration or raising the starting pressure can reduce the window of inadequate CO₂ flushing.
Do not block your vents: It might seem logical to cover some vent holes to reduce air noise or drafts, but doing so directly impairs CO₂ clearance and can create a genuinely dangerous situation.
Report persistent symptoms: Morning headaches, confusion, or a feeling of suffocation that does not resolve with mask adjustments warrants a conversation with your sleep provider about CO₂ monitoring.

For patients with underlying lung disease or obesity hypoventilation syndrome, the more important conversation is whether CPAP is the right modality at all, or whether bilevel or volume-assured pressure support would better address both the airway obstruction and the ventilation deficit. That decision belongs with a sleep specialist or pulmonologist who can review overnight CO₂ data, not with a machine algorithm.

Why Most CPAP Users Do Not Need to Worry

The research on CPAP rebreathing can sound alarming in isolation, but context matters. The vast majority of adults using CPAP for garden-variety obstructive sleep apnea breathe at normal rates, use modern masks with adequate vent designs, and run their machines at pressures that provide sufficient flush flow. For this population, the amount of CO₂ rebreathing is well below thresholds that would cause symptoms, let alone poisoning. The people at genuine risk are those using very low pressures, those with underlying conditions that impair CO₂ elimination, those using masks with poor vent performance or clogged exhaust ports, and those in the rare scenario of device failure during sleep.

Researchers have been clear that rebreathing risk factors are poorly understood in everyday clinical practice and that many sleep labs do not routinely assess CO₂ during titration studies.⁵ That gap does not mean the problem is common or severe for most users. It means that when it does occur, it tends to be missed or attributed to something else. Awareness, not alarm, is the appropriate response.

1
PubMed. Circuit-dependent carbon dioxide rebreathing during continuous positive airway pressure
2
PubMed Central. Rebreathing during CPAP therapy and its implications in obstructive sleep apnea – Section: N/A
3
PubMed. Experimental assessment of CO2 rebreathing in closed-circuit CPAP therapy with different non-invasive interfaces
4
Monaldi Archives for Chest Disease. Carbon dioxide rebreathing in non-invasive ventilation. Analysis of masks, expiratory ports and ventilatory modes
5
PubMed. Circuit-dependent carbon dioxide rebreathing during continuous positive airway pressure – Section: BACKGROUND
6
PubMed. Potential rebreathing after continuous positive airway pressure failure during sleep
7
PubMed. Performance of different continuous positive airway pressure helmets equipped with safety valves during failure of fresh gas supply
8
PubMed Central. The Effect of Supplemental Oxygen in Obesity Hypoventilation Syndrome
9
PubMed Central. The level of carbon dioxide is the determinant of successful noninvasive ventilation pressure titration in patients with nonhypercapnic primary central sleep apnea: a case report
10
PubMed Central. A pilot randomized trial comparing CPAP vs bilevel PAP spontaneous mode in the treatment of hypoventilation disorder in patients with obesity and obstructive airway disease
11
Bioscientia Medicina : Journal of Biomedicine and Translational Research. Continuous Positive Airway Pressure (CPAP) versus Non-Invasive Ventilation (NIV) in Obesity Hypoventilation Syndrome: A Meta-Analysis
12
PubMed Central. CPAP titration failure is not equivalent to long-term CPAP treatment failure in patients with obesity hypoventilation syndrome: a case series
13
PubMed Central. Neuromuscular disorders and sleep in critically ill patients
14
PubMed Central. Assessing Modeled CO2 Retention and Rebreathing of a Facemask Designed for Efficient Delivery of Aerosols to Infants
15
Frontiers in Sleep. Enhanced expiratory rebreathing space for high loop gain sleep apnea treatment – Section: Creating EERS